Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer characterized by the absence of expression of progesterone receptor (PR), estrogen receptor (ER), and epidermal growth factor receptor-2 (HER2) (Yin et al., 2020). Here, ESR1 is linked to triple-negative breast carcinoma.